Skip to main content

Table 1 Key characteristics of the included systematic reviews and Risk of bias of each review

From: Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews

Authors, date of publicationa

PICOSb

Dates of last search

Databases searched (n)

Risk of Bias and quality of evidence tools

Total number of studies/Number of studies relevant to the overview (designs)c,d

Risk of bias of the review (assessed using ROBIS tool)

Quantitative synthesis- meta-analysis

 Aspinall, 2014 [27]

P: PWID

I: NSP (Specialist sites, pharmacies or outreach services)

C: No, rare, or less exposure to NSP

O: HIV incidence

S: any

2012

CINAHL, Cochrane Library, EMBASE, IBSS, MEDLINE and PsycINFO (6)

Newcastle-Ottawa each study & GRADE to assess quality of evidence as a whole

12/12 (11 CC/Co; 1 OTH)

Low

 Hagan, 2011 [34]

P: individuals who could conceivably have acquired HCV infection via administration of an illegal drug (PWID among them)

I: interventions that could prevent HCV infection

C:NR

O: HCV prevalence or incidence rates, and measures of association with prevalence or incidence

S: any

2010

Current Contents, Dissertation Abstracts, ERIC, NIH CRISP, MEDLINE, PsycINFO, Sociological Abstracts (7)

Developed their own quality scale

26/7 (7 CC/Co)

High

 Turner, 2011 [32]

P: PWID in the UK

I: NSP or OST (or combination)

C: OST vs non OST; high vs low coverage of NSP

O: HCV infection and IRB

S: any

NR

PubMed and Web of Science (2)

None

4/3 (1 CC/Co; 2 OTH)

High

 Cross, 1998 [26]

P: PWID

I: NSP or educational programmes

C: NR

O: IRB

S: experimental or quasi-experimental design

1995

AIDSLINE, MEDLINE, PsycINFO, Social Science Citation Index (4)

None

26/10 (1 RCT; 9 OTH)

High

Qualitative synthesis

 Abdul-Quader, 2013 [29]

P: PWID

I: Structural interventions that address external factors to reduce HIV and HCV

C: any quantitative comparison

O: Changes in HIV/HCV in relation to intervention

S: controlled or before & after

2011

Cochrane Central Register of Controlled Trials, EMBASE, LILACS, PsycINFO, PubMed, and the Web of Science/Web of Social Science (6)

WHO-Johns Hopkins 9-Point Rigour Scale.

15/15 (1 CC/Co; 14 OTH)

Unclear

 Des Jarlais, 2013 [28]

P: PWID in low-and middle income and transitional countries (LMICs)

I: NSP

C: any

O: changes in prevalence or incidence of HIV, HCV, HIV/ HCV co-infection or

changes over time in newly reported HIV or HCV cases of infection

S: any

2011

EMBASE, NLM Gateway, PubMed, Web of Science (4)

None

13/13 (13 OTH)

High

 Hong and Li, 2009 [31]

P: People with HIV/ AIDS in China

I: Any behavioural intervention

C: Any

O: Rate of needle-sharing

S: Any

2008

AIDSLine, EBSCO, FirstSearch, PsycINFO, PubMed (4)

None

25/3 (1 RCT; 1 CC/Co; 1 OTH)

High

 Jones, 2008 [12]

P: PWID

I: NSP

C: any

O: IRB, HIV, HVC

S: RCT, controlled non-randomised studies, controlled and uncontrolled before and after studies, cross-sectional studies, cohort studies, case-control studies and ecological studies

2008

ACP Journal Club, ASSIA, CINAHL, Cochrane Library,

EMBASE, EPPI-Centre databases, Health Information Management Consortium, IBSS, MEDLINE, National Research Register Archive, OpenSIGLE, Project CORK,

PsycINFO,

Sociological Abstracts,

SOMED (15)

Quality assessment tools developed by NICE Centre for Public Health Excellence, England and Wales and the Effective Public Health Practice Project, Canada

24/15 (2 RCT; 1 CC/Co; 12 OTH)

Low

 Kall, 2007 [30]

P: PWID

I: NSPs

C: control or comparison groups

O: HIV incidence or prevalence

S: any

2005

MEDLINE and PsyclNFO (2)

None

16/16 (8 CC/Co; 8 OTH)

High

 Wright, 2006 [33]

P: PWID

I: primary prevention intervention targeting injecting drug use

C: any

O: HCV prevalence and incidence

S: intervention or observational studies

2003

Cochrane Library, CINAHL, EMBASE, MEDLINE and PsycINFO (4)

Developed their own quality scale

18/12 (9 CC/Co; 3 OTH)

High

 Tilson, 2006 [24]

P: PWID

I: NSP

C: With and without OST; Placebo.

O: IRB, HCV and HIV

S: NR

2006

Cochrane Library, Grey Literature Report, EMBASE, PubMed,

PsycINFO, Social Science

Abstracts, Web of Science, WorldCat (8)

GRADE

45/43 (28 CC/Co; 15 OTH)

Unclear

 Gibson, 2001 [35]

P:PWID

I:NSP

C: any

O:HIV, HBV, HCV and IRB

S:any

1999

Medline and PsycINFO (2)

None

42/32 (19 CC/Co; 13 OTH)

High

 Leonard, 1999 [25]

P: PWID

I: NSP

C: Any comparator group (but none was not allowed)

O: HIV, HCV and IRB

S: NR

1999

AIDSLINE, CINAHL, Cochrane Library, EMBASE, MEDLINE, PHEffect (6)

Quality assessment tools developed by the Effective Public Health Practice Project team, Canada

21/19 (15 CC/Co; 4 OTH)

Unclear

  1. aCategorized by type of synthesis and listed by publication date
  2. bPICOS: acronym for Population, Intervention, Comparator, Outcome and Study Design
  3. cClassified by authors of the review
  4. dCC/Co: Case-Control/Cohort; RCT: Randomized Control Trial; OTH: other (time-series designs, before-after studies, ecological studies)